☑ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 94-1697231 | |||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
Common Stock, $0.05 par value | GPS | The New York Stock Exchange |
Large accelerated filer | ☑ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||||||||||
Emerging growth company | ☐ |
Page | ||||||||
Item 1. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 5. | ||||||||
Item 6. |
($ and shares in millions except par value) | October 28, 2023 | January 28, 2023 | October 29, 2022 | ||||||||||||||
ASSETS | |||||||||||||||||
Current assets: | |||||||||||||||||
Cash and cash equivalents | $ | 1,351 | $ | 1,215 | $ | 679 | |||||||||||
Merchandise inventory | 2,377 | 2,389 | 3,043 | ||||||||||||||
Other current assets | 646 | 1,013 | 1,316 | ||||||||||||||
Total current assets | 4,374 | 4,617 | 5,038 | ||||||||||||||
Property and equipment, net of accumulated depreciation of $4,890, $4,837, and $4,957 | 2,552 | 2,688 | 2,788 | ||||||||||||||
Operating lease assets | 3,200 | 3,173 | 3,341 | ||||||||||||||
Other long-term assets | 926 | 908 | 833 | ||||||||||||||
Total assets | $ | 11,052 | $ | 11,386 | $ | 12,000 | |||||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Accounts payable | $ | 1,433 | $ | 1,320 | $ | 1,388 | |||||||||||
Accrued expenses and other current liabilities | 1,078 | 1,219 | 1,245 | ||||||||||||||
Current portion of operating lease liabilities | 604 | 667 | 691 | ||||||||||||||
Income taxes payable | 24 | 50 | 57 | ||||||||||||||
Total current liabilities | 3,139 | 3,256 | 3,381 | ||||||||||||||
Long-term liabilities: | |||||||||||||||||
Revolving credit facility | — | 350 | 350 | ||||||||||||||
Long-term debt | 1,488 | 1,486 | 1,486 | ||||||||||||||
Long-term operating lease liabilities | 3,456 | 3,517 | 3,673 | ||||||||||||||
Other long-term liabilities | 509 | 544 | 539 | ||||||||||||||
Total long-term liabilities | 5,453 | 5,897 | 6,048 | ||||||||||||||
Commitments and contingencies (see Note 10) | |||||||||||||||||
Stockholders’ equity: | |||||||||||||||||
Common stock $0.05 par value | |||||||||||||||||
Authorized 2,300 shares for all periods presented; Issued and Outstanding 371, 366, and 365 shares | 18 | 18 | 18 | ||||||||||||||
Additional paid-in capital | 93 | 27 | 16 | ||||||||||||||
Retained earnings | 2,291 | 2,140 | 2,468 | ||||||||||||||
Accumulated other comprehensive income | 58 | 48 | 69 | ||||||||||||||
Total stockholders’ equity | 2,460 | 2,233 | 2,571 | ||||||||||||||
Total liabilities and stockholders’ equity | $ | 11,052 | $ | 11,386 | $ | 12,000 |
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
($ and shares in millions except per share amounts) | October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | |||||||||||||||||||
Net sales | $ | 3,767 | $ | 4,039 | $ | 10,591 | $ | 11,373 | |||||||||||||||
Cost of goods sold and occupancy expenses | 2,211 | 2,530 | 6,488 | 7,438 | |||||||||||||||||||
Gross profit | 1,556 | 1,509 | 4,103 | 3,935 | |||||||||||||||||||
Operating expenses | 1,306 | 1,323 | 3,757 | 3,974 | |||||||||||||||||||
Operating income (loss) | 250 | 186 | 346 | (39) | |||||||||||||||||||
Interest expense | 28 | 22 | 66 | 63 | |||||||||||||||||||
Interest income | (28) | (4) | (58) | (6) | |||||||||||||||||||
Income (loss) before income taxes | 250 | 168 | 338 | (96) | |||||||||||||||||||
Income tax expense (benefit) | 32 | (114) | 21 | (167) | |||||||||||||||||||
Net income | $ | 218 | $ | 282 | $ | 317 | $ | 71 | |||||||||||||||
Weighted-average number of shares - basic | 371 | 365 | 369 | 367 | |||||||||||||||||||
Weighted-average number of shares - diluted | 375 | 366 | 373 | 370 | |||||||||||||||||||
Earnings per share - basic | $ | 0.59 | $ | 0.77 | $ | 0.86 | $ | 0.19 | |||||||||||||||
Earnings per share - diluted | $ | 0.58 | $ | 0.77 | $ | 0.85 | $ | 0.19 | |||||||||||||||
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
($ in millions) | October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | |||||||||||||||||||
Net income | $ | 218 | $ | 282 | $ | 317 | $ | 71 | |||||||||||||||
Other comprehensive income, net of tax | |||||||||||||||||||||||
Foreign currency translation | 5 | 6 | 1 | 13 | |||||||||||||||||||
Change in fair value of derivative financial instruments, net of tax expense of $1, $1, $3, $3 | 16 | 31 | 22 | 40 | |||||||||||||||||||
Reclassification adjustment for gains on derivative financial instruments, net of tax benefit of $1, $—, $—, $— | (7) | (14) | (13) | (22) | |||||||||||||||||||
Other comprehensive income, net of tax | 14 | 23 | 10 | 31 | |||||||||||||||||||
Comprehensive income | $ | 232 | $ | 305 | $ | 327 | $ | 102 |
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income | |||||||||||||||||||||||||||||||||||
($ and shares in millions except per share amounts) | Shares | Amount | Total | |||||||||||||||||||||||||||||||||||
Balance as of July 29, 2023 | 369 | $ | 18 | $ | 73 | $ | 2,128 | $ | 44 | $ | 2,263 | |||||||||||||||||||||||||||
Net income for the 13 weeks ended October 28, 2023 | 218 | 218 | ||||||||||||||||||||||||||||||||||||
Other comprehensive income, net of tax | ||||||||||||||||||||||||||||||||||||||
Foreign currency translation | 5 | 5 | ||||||||||||||||||||||||||||||||||||
Change in fair value of derivative financial instruments | 16 | 16 | ||||||||||||||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income | (7) | (7) | ||||||||||||||||||||||||||||||||||||
Issuance of common stock related to stock options and employee stock purchase plans | 1 | — | 5 | 5 | ||||||||||||||||||||||||||||||||||
Issuance of common stock and withholding tax payments related to vesting of stock units | 1 | — | (5) | (5) | ||||||||||||||||||||||||||||||||||
Share-based compensation, net of forfeitures | 20 | 20 | ||||||||||||||||||||||||||||||||||||
Common stock dividends declared and paid ($0.15 per share) | (55) | (55) | ||||||||||||||||||||||||||||||||||||
Balance as of October 28, 2023 | 371 | $ | 18 | $ | 93 | $ | 2,291 | $ | 58 | $ | 2,460 | |||||||||||||||||||||||||||
Balance as of July 30, 2022 | 364 | $ | 18 | $ | — | $ | 2,241 | $ | 46 | $ | 2,305 | |||||||||||||||||||||||||||
Net income for the 13 weeks ended October 29, 2022 | 282 | 282 | ||||||||||||||||||||||||||||||||||||
Other comprehensive income, net of tax | ||||||||||||||||||||||||||||||||||||||
Foreign currency translation | 6 | 6 | ||||||||||||||||||||||||||||||||||||
Change in fair value of derivative financial instruments | 31 | 31 | ||||||||||||||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income | (14) | (14) | ||||||||||||||||||||||||||||||||||||
Repurchases and retirement of common stock | (2) | — | (12) | (12) | ||||||||||||||||||||||||||||||||||
Issuance of common stock related to stock options and employee stock purchase plans | 1 | — | 8 | 8 | ||||||||||||||||||||||||||||||||||
Issuance of common stock and withholding tax payments related to vesting of stock units | 2 | — | (2) | (2) | ||||||||||||||||||||||||||||||||||
Share-based compensation, net of forfeitures | 22 | 22 | ||||||||||||||||||||||||||||||||||||
Common stock dividends declared and paid ($0.15 per share) | (55) | (55) | ||||||||||||||||||||||||||||||||||||
Balance as of October 29, 2022 | 365 | $ | 18 | $ | 16 | $ | 2,468 | $ | 69 | $ | 2,571 |
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income | |||||||||||||||||||||||||||||||||||
($ and shares in millions except per share amounts) | Shares | Amount | Total | |||||||||||||||||||||||||||||||||||
Balance as of January 28, 2023 | 366 | $ | 18 | $ | 27 | $ | 2,140 | $ | 48 | $ | 2,233 | |||||||||||||||||||||||||||
Net income for the 39 weeks ended October 28, 2023 | 317 | 317 | ||||||||||||||||||||||||||||||||||||
Other comprehensive income, net of tax | ||||||||||||||||||||||||||||||||||||||
Foreign currency translation | 1 | 1 | ||||||||||||||||||||||||||||||||||||
Change in fair value of derivative financial instruments | 22 | 22 | ||||||||||||||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income | (13) | (13) | ||||||||||||||||||||||||||||||||||||
Issuance of common stock related to stock options and employee stock purchase plans | 2 | — | 18 | 18 | ||||||||||||||||||||||||||||||||||
Issuance of common stock and withholding tax payments related to vesting of stock units | 3 | — | (16) | (16) | ||||||||||||||||||||||||||||||||||
Share-based compensation, net of forfeitures | 64 | 64 | ||||||||||||||||||||||||||||||||||||
Common stock dividends declared and paid ($0.45 per share) | (166) | (166) | ||||||||||||||||||||||||||||||||||||
Balance as of October 28, 2023 | 371 | $ | 18 | $ | 93 | $ | 2,291 | $ | 58 | $ | 2,460 | |||||||||||||||||||||||||||
Balance as of January 29, 2022 | 371 | $ | 19 | $ | 43 | $ | 2,622 | $ | 38 | $ | 2,722 | |||||||||||||||||||||||||||
Net income for the 39 weeks ended October 29, 2022 | 71 | 71 | ||||||||||||||||||||||||||||||||||||
Other comprehensive income, net of tax | ||||||||||||||||||||||||||||||||||||||
Foreign currency translation | 13 | 13 | ||||||||||||||||||||||||||||||||||||
Change in fair value of derivative financial instruments | 40 | 40 | ||||||||||||||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income | (22) | (22) | ||||||||||||||||||||||||||||||||||||
Repurchases and retirement of common stock | (11) | (1) | (63) | (59) | (123) | |||||||||||||||||||||||||||||||||
Issuance of common stock related to stock options and employee stock purchase plans | 2 | — | 23 | 23 | ||||||||||||||||||||||||||||||||||
Issuance of common stock and withholding tax payments related to vesting of stock units | 3 | — | (17) | (17) | ||||||||||||||||||||||||||||||||||
Share-based compensation, net of forfeitures | 30 | 30 | ||||||||||||||||||||||||||||||||||||
Common stock dividends declared and paid ($0.45 per share) | (166) | (166) | ||||||||||||||||||||||||||||||||||||
Balance as of October 29, 2022 | 365 | $ | 18 | $ | 16 | $ | 2,468 | $ | 69 | $ | 2,571 |
39 Weeks Ended | |||||||||||
($ in millions) | October 28, 2023 | October 29, 2022 | |||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ | 317 | $ | 71 | |||||||
Adjustments to reconcile net income to net cash provided by (used for) operating activities: | |||||||||||
Depreciation and amortization | 394 | 402 | |||||||||
Share-based compensation | 64 | 28 | |||||||||
Impairment of operating lease assets | — | 16 | |||||||||
Impairment of store assets | 2 | 10 | |||||||||
Amortization of debt issuance costs | 3 | 5 | |||||||||
Non-cash and other items | 36 | (8) | |||||||||
Loss on divestiture activity | — | 35 | |||||||||
Gain on sale of building | (47) | (83) | |||||||||
Deferred income taxes | (27) | 32 | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Merchandise inventory | (5) | (78) | |||||||||
Other current assets and other long-term assets | 81 | (34) | |||||||||
Accounts payable | 133 | (503) | |||||||||
Accrued expenses and other current liabilities | (11) | (123) | |||||||||
Income taxes payable, net of receivables and other tax-related items | 50 | 216 | |||||||||
Other long-term liabilities | (11) | (7) | |||||||||
Operating lease assets and liabilities, net | (147) | (91) | |||||||||
Net cash provided by (used for) operating activities | 832 | (112) | |||||||||
Cash flows from investing activities: | |||||||||||
Purchases of property and equipment | (288) | (577) | |||||||||
Net proceeds from sale of buildings | 76 | 458 | |||||||||
Net proceeds from divestiture activity | 9 | — | |||||||||
Net cash used for investing activities | (203) | (119) | |||||||||
Cash flows from financing activities: | |||||||||||
Proceeds from revolving credit facility | — | 350 | |||||||||
Repayments of revolving credit facility | (350) | — | |||||||||
Payments for debt issuance costs | — | (6) | |||||||||
Proceeds from issuances under share-based compensation plans | 18 | 23 | |||||||||
Withholding tax payments related to vesting of stock units | (16) | (17) | |||||||||
Repurchases of common stock | — | (123) | |||||||||
Cash dividends paid | (166) | (166) | |||||||||
Other | (2) | (1) | |||||||||
Net cash provided by (used for) financing activities | (516) | 60 | |||||||||
Effect of foreign exchange rate fluctuations on cash, cash equivalents, and restricted cash | (7) | (25) | |||||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash | 106 | (196) | |||||||||
Cash, cash equivalents, and restricted cash at beginning of period | 1,273 | 902 | |||||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 1,379 | $ | 706 | |||||||
Supplemental disclosure of cash flow information: | |||||||||||
Cash paid for interest during the period | $ | 72 | $ | 70 | |||||||
Cash paid for income taxes during the period, net of refunds | $ | (1) | $ | (407) | |||||||
($ in millions) | October 28, 2023 | January 28, 2023 | October 29, 2022 | ||||||||||||||
Cash and cash equivalents, per Condensed Consolidated Balance Sheets | $ | 1,351 | $ | 1,215 | $ | 679 | |||||||||||
Restricted cash included in other current assets | — | 32 | 1 | ||||||||||||||
Restricted cash included in other long-term assets | 28 | 26 | 26 | ||||||||||||||
Total cash, cash equivalents, and restricted cash, per Condensed Consolidated Statements of Cash Flows | $ | 1,379 | $ | 1,273 | $ | 706 |
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
($ in millions) | October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | |||||||||||||||||||
Store and franchise sales | $ | 2,331 | $ | 2,478 | $ | 6,771 | $ | 7,168 | |||||||||||||||
Online sales (1) | 1,436 | 1,561 | 3,820 | 4,205 | |||||||||||||||||||
Total net sales | $ | 3,767 | $ | 4,039 | $ | 10,591 | $ | 11,373 | |||||||||||||||
($ in millions) | Old Navy Global | Gap Global | Banana Republic Global | Athleta Global | Other (2) | Total | ||||||||||||||||||||||||||||||||
13 Weeks Ended October 28, 2023 | ||||||||||||||||||||||||||||||||||||||
U.S. (1) | $ | 1,917 | $ | 664 | $ | 398 | $ | 267 | $ | 15 | $ | 3,261 | ||||||||||||||||||||||||||
Canada | 193 | 96 | 42 | 10 | — | 341 | ||||||||||||||||||||||||||||||||
Europe | — | 29 | 1 | — | — | 30 | ||||||||||||||||||||||||||||||||
Asia | 1 | 71 | 12 | — | — | 84 | ||||||||||||||||||||||||||||||||
Other regions | 15 | 27 | 7 | 2 | — | 51 | ||||||||||||||||||||||||||||||||
Total | $ | 2,126 | $ | 887 | $ | 460 | $ | 279 | $ | 15 | $ | 3,767 |
($ in millions) | Old Navy Global | Gap Global | Banana Republic Global | Athleta Global | Other (2) | Total | ||||||||||||||||||||||||||||||||
13 Weeks Ended October 29, 2022 | ||||||||||||||||||||||||||||||||||||||
U.S. (1) | $ | 1,936 | $ | 690 | $ | 448 | $ | 326 | $ | 4 | $ | 3,404 | ||||||||||||||||||||||||||
Canada | 184 | 95 | 47 | 7 | — | 333 | ||||||||||||||||||||||||||||||||
Europe | 1 | 58 | 1 | 1 | — | 61 | ||||||||||||||||||||||||||||||||
Asia | — | 143 | 14 | — | — | 157 | ||||||||||||||||||||||||||||||||
Other regions | 16 | 55 | 7 | 6 | — | 84 | ||||||||||||||||||||||||||||||||
Total | $ | 2,137 | $ | 1,041 | $ | 517 | $ | 340 | $ | 4 | $ | 4,039 |
($ in millions) | Old Navy Global | Gap Global | Banana Republic Global | Athleta Global | Other (2) | Total | ||||||||||||||||||||||||||||||||
39 Weeks Ended October 28, 2023 | ||||||||||||||||||||||||||||||||||||||
U.S. (1) | $ | 5,353 | $ | 1,702 | $ | 1,187 | $ | 903 | $ | 29 | $ | 9,174 | ||||||||||||||||||||||||||
Canada | 503 | 233 | 122 | 33 | — | 891 | ||||||||||||||||||||||||||||||||
Europe | 1 | 87 | 2 | 1 | — | 91 | ||||||||||||||||||||||||||||||||
Asia | 2 | 225 | 40 | — | — | 267 | ||||||||||||||||||||||||||||||||
Other regions | 56 | 87 | 21 | 4 | — | 168 | ||||||||||||||||||||||||||||||||
Total | $ | 5,915 | $ | 2,334 | $ | 1,372 | $ | 941 | $ | 29 | $ | 10,591 |
($ in millions) | Old Navy Global | Gap Global | Banana Republic Global | Athleta Global | Other (2) | Total | ||||||||||||||||||||||||||||||||
39 Weeks Ended October 29, 2022 | ||||||||||||||||||||||||||||||||||||||
U.S. (1) | $ | 5,489 | $ | 1,752 | $ | 1,324 | $ | 1,005 | $ | 10 | $ | 9,580 | ||||||||||||||||||||||||||
Canada | 514 | 241 | 143 | 23 | — | 921 | ||||||||||||||||||||||||||||||||
Europe | 2 | 163 | 4 | 3 | — | 172 | ||||||||||||||||||||||||||||||||
Asia | 1 | 425 | 48 | — | — | 474 | ||||||||||||||||||||||||||||||||
Other regions | 62 | 132 | 19 | 13 | — | 226 | ||||||||||||||||||||||||||||||||
Total | $ | 6,068 | $ | 2,713 | $ | 1,538 | $ | 1,044 | $ | 10 | $ | 11,373 |
13 Weeks Ended October 28, 2023 | 39 Weeks Ended October 28, 2023 | ||||||||||||||||||||||||||||||||||
($ in millions) | Cost of Goods Sold and Occupancy Expenses | Operating Expenses | Total Costs | Cost of Goods Sold and Occupancy Expenses | Operating Expenses | Total Costs | |||||||||||||||||||||||||||||
Employee-related costs | $ | — | $ | (1) | $ | (1) | $ | 4 | $ | 60 | $ | 64 | |||||||||||||||||||||||
Consulting and other associated costs | — | 6 | 6 | — | 29 | 29 | |||||||||||||||||||||||||||||
Total restructuring costs | $ | — | $ | 5 | $ | 5 | $ | 4 | $ | 89 | $ | 93 |
($ in millions) | Employee-Related Costs | Consulting and Other Associated Costs | Total | ||||||||||||||
Balance at January 28, 2023 | $ | — | $ | — | $ | — | |||||||||||
13 Weeks Ended April 29, 2023 | |||||||||||||||||
Provision | 62 | 13 | 75 | ||||||||||||||
Cash payments | — | (10) | (10) | ||||||||||||||
Balance at April 29, 2023 | 62 | 3 | 65 | ||||||||||||||
13 Weeks Ended July 29, 2023 | |||||||||||||||||
Provision | 3 | 10 | 13 | ||||||||||||||
Cash payments | (45) | (7) | (52) | ||||||||||||||
Balance at July 29, 2023 | 20 | 6 | 26 | ||||||||||||||
13 Weeks Ended October 28, 2023 | |||||||||||||||||
Provision | — | 6 | 6 | ||||||||||||||
Adjustments | (1) | — | (1) | ||||||||||||||
Cash payments | (11) | (12) | (23) | ||||||||||||||
Balance at October 28, 2023 | $ | 8 | $ | — | $ | 8 |
($ in millions) | October 28, 2023 | January 28, 2023 | October 29, 2022 | ||||||||||||||
2029 Notes | $ | 750 | $ | 750 | $ | 750 | |||||||||||
2031 Notes | 750 | 750 | 750 | ||||||||||||||
Less: Unamortized debt issuance costs | (12) | (14) | (14) | ||||||||||||||
Total long-term debt | $ | 1,488 | $ | 1,486 | $ | 1,486 |
Scheduled Maturity ($ in millions) | Principal | Interest Rate | Interest Payments | ||||||||||||||
October 1, 2029 (1) | $ | 750 | 3.625 | % | Semi-Annual | ||||||||||||
October 1, 2031 (2) | 750 | 3.875 | % | Semi-Annual | |||||||||||||
Total issuance | $ | 1,500 |
Fair Value Measurements at Reporting Date Using | |||||||||||||||||||||||
($ in millions) | October 28, 2023 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents | $ | 1 | $ | — | $ | 1 | $ | — | |||||||||||||||
Derivative financial instruments | 34 | — | 34 | — | |||||||||||||||||||
Deferred compensation plan assets | 31 | 31 | — | — | |||||||||||||||||||
Other assets | 4 | — | — | 4 | |||||||||||||||||||
Total | $ | 70 | $ | 31 | $ | 35 | $ | 4 | |||||||||||||||
Liabilities: | |||||||||||||||||||||||
Derivative financial instruments | $ | — | $ | — | $ | — | $ | — | |||||||||||||||
Fair Value Measurements at Reporting Date Using | |||||||||||||||||||||||
($ in millions) | January 28, 2023 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents | $ | 15 | $ | — | $ | 15 | $ | — | |||||||||||||||
Derivative financial instruments | 11 | — | 11 | — | |||||||||||||||||||
Deferred compensation plan assets | 34 | 34 | — | — | |||||||||||||||||||
Other assets | 4 | — | — | 4 | |||||||||||||||||||
Total | $ | 64 | $ | 34 | $ | 26 | $ | 4 | |||||||||||||||
Liabilities: | |||||||||||||||||||||||
Derivative financial instruments | $ | 20 | $ | — | $ | 20 | $ | — | |||||||||||||||
Fair Value Measurements at Reporting Date Using | |||||||||||||||||||||||
($ in millions) | October 29, 2022 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents | $ | 19 | $ | — | $ | 19 | $ | — | |||||||||||||||
Derivative financial instruments | 46 | — | 46 | — | |||||||||||||||||||
Deferred compensation plan assets | 37 | 37 | — | — | |||||||||||||||||||
Other assets | 4 | — | — | 4 | |||||||||||||||||||
Total | $ | 106 | $ | 37 | $ | 65 | $ | 4 | |||||||||||||||
Liabilities: | |||||||||||||||||||||||
Derivative financial instruments | $ | 2 | $ | — | $ | 2 | $ | — |
($ in millions) | October 28, 2023 | January 28, 2023 | October 29, 2022 | ||||||||||||||
Derivatives designated as cash flow hedges | $ | 357 | $ | 441 | $ | 491 | |||||||||||
Derivatives not designated as hedging instruments | 526 | 645 | 583 | ||||||||||||||
Total | $ | 883 | $ | 1,086 | $ | 1,074 |
($ in millions) | October 28, 2023 | January 28, 2023 | October 29, 2022 | ||||||||||||||
Derivatives designated as cash flow hedges: | |||||||||||||||||
Other current assets | $ | 13 | $ | 9 | $ | 25 | |||||||||||
Other long-term assets | 2 | — | 4 | ||||||||||||||
Accrued expenses and other current liabilities | — | 5 | — | ||||||||||||||
Other long-term liabilities | — | — | — | ||||||||||||||
Derivatives not designated as hedging instruments: | |||||||||||||||||
Other current assets | 19 | 2 | 17 | ||||||||||||||
Accrued expenses and other current liabilities | — | 15 | 2 | ||||||||||||||
Total derivatives in an asset position | $ | 34 | $ | 11 | $ | 46 | |||||||||||
Total derivatives in a liability position | $ | — | $ | 20 | $ | 2 |
Location and Amount of Gain Recognized in Net Income | |||||||||||||||||||||||
13 Weeks Ended October 28, 2023 | 13 Weeks Ended October 29, 2022 | ||||||||||||||||||||||
($ in millions) | Cost of goods sold and occupancy expenses | Operating expenses | Cost of goods sold and occupancy expenses | Operating expenses | |||||||||||||||||||
Total amount of expense line items presented in the Condensed Consolidated Statements of Operations in which the effects of derivatives are recorded | $ | 2,211 | $ | 1,306 | $ | 2,530 | $ | 1,323 | |||||||||||||||
Gain recognized in net income | |||||||||||||||||||||||
Derivatives designated as cash flow hedges | (6) | — | (14) | — | |||||||||||||||||||
Derivatives not designated as hedging instruments | — | (27) | — | (51) | |||||||||||||||||||
Total gain recognized in net income | $ | (6) | $ | (27) | $ | (14) | $ | (51) |
Location and Amount of Gain Recognized in Net Income | |||||||||||||||||||||||
39 Weeks Ended October 28, 2023 | 39 Weeks Ended October 29, 2022 | ||||||||||||||||||||||
($ in millions) | Cost of goods sold and occupancy expense | Operating expenses | Cost of goods sold and occupancy expense | Operating expenses | |||||||||||||||||||
Total amount of expense line items presented in the Condensed Consolidated Statements of Operations in which the effects of derivatives are recorded | $ | 6,488 | $ | 3,757 | $ | 7,438 | $ | 3,974 | |||||||||||||||
Gain recognized in net income | |||||||||||||||||||||||
Derivatives designated as cash flow hedges | (13) | — | (22) | — | |||||||||||||||||||
Derivatives not designated as hedging instruments | — | (25) | — | (80) | |||||||||||||||||||
Total gain recognized in net income | $ | (13) | $ | (25) | $ | (22) | $ | (80) |
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
($ and shares in millions except average per share cost) | October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | |||||||||||||||||||
Number of shares repurchased (1) | — | 1.2 | — | 10.6 | |||||||||||||||||||
Total cost | $ | — | $ | 12 | $ | — | $ | 123 | |||||||||||||||
Average per share cost including commissions | $ | — | $ | 10.20 | $ | — | $ | 11.59 |
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
(shares in millions) | October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | |||||||||||||||||||
Weighted-average number of shares - basic | 371 | 365 | 369 | 367 | |||||||||||||||||||
Common stock equivalents | 4 | 1 | 4 | 3 | |||||||||||||||||||
Weighted-average number of shares - diluted | 375 | 366 | 373 | 370 |
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | ||||||||||||||||||||
Old Navy Global | 1 | % | (1) | % | (2) | % | (13) | % | |||||||||||||||
Gap Global | (1) | % | 4 | % | — | % | (4) | % | |||||||||||||||
Banana Republic Global | (8) | % | 10 | % | (8) | % | 14 | % | |||||||||||||||
Athleta Global | (19) | % | — | % | (13) | % | (5) | % | |||||||||||||||
The Gap, Inc. | (2) | % | 1 | % | (3) | % | (8) | % |
January 28, 2023 | 39 Weeks Ended October 28, 2023 | October 28, 2023 | |||||||||||||||||||||||||||
Number of Store Locations | Number of Stores Opened | Number of Stores Closed | Number of Store Locations | Square Footage (in millions) | |||||||||||||||||||||||||
Old Navy North America | 1,238 | 24 | 11 | 1,251 | 19.9 | ||||||||||||||||||||||||
Gap North America | 493 | 1 | 14 | 480 | 5.1 | ||||||||||||||||||||||||
Gap Asia (1) | 232 | 1 | 7 | 137 | 1.2 | ||||||||||||||||||||||||
Banana Republic North America | 419 | 2 | 13 | 408 | 3.4 | ||||||||||||||||||||||||
Banana Republic Asia | 46 | 4 | 2 | 48 | 0.2 | ||||||||||||||||||||||||
Athleta North America | 257 | 24 | 7 | 274 | 1.1 | ||||||||||||||||||||||||
Company-operated stores total | 2,685 | 56 | 54 | 2,598 | 30.9 | ||||||||||||||||||||||||
Franchise (1) | 667 | 219 | 85 | 935 | N/A | ||||||||||||||||||||||||
Total | 3,352 | 275 | 139 | 3,533 | 30.9 | ||||||||||||||||||||||||
Increase (decrease) over prior year | 4.5 | % | (4.6) | % | |||||||||||||||||||||||||
January 29, 2022 | 39 Weeks Ended October 29, 2022 | October 29, 2022 | |||||||||||||||||||||||||||
Number of Store Locations | Number of Stores Opened | Number of Stores Closed | Number of Store Locations | Square Footage (in millions) | |||||||||||||||||||||||||
Old Navy North America (2) | 1,252 | 25 | 6 | 1,247 | 20.0 | ||||||||||||||||||||||||
Gap North America | 520 | 2 | 18 | 504 | 5.4 | ||||||||||||||||||||||||
Gap Asia | 329 | 4 | 74 | 259 | 2.2 | ||||||||||||||||||||||||
Gap Europe (3) | 11 | — | — | — | — | ||||||||||||||||||||||||
Banana Republic North America | 446 | 2 | 15 | 433 | 3.6 | ||||||||||||||||||||||||
Banana Republic Asia | 50 | 2 | 3 | 49 | 0.2 | ||||||||||||||||||||||||
Athleta North America | 227 | 29 | 5 | 251 | 1.0 | ||||||||||||||||||||||||
Company-operated stores total | 2,835 | 64 | 121 | 2,743 | 32.4 | ||||||||||||||||||||||||
Franchise (2) (3) | 564 | 77 | 39 | 637 | N/A | ||||||||||||||||||||||||
Total | 3,399 | 141 | 160 | 3,380 | 32.4 | ||||||||||||||||||||||||
Decrease over prior year | (2.3) | % | (3.9) | % |
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
($ in millions) | October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | |||||||||||||||||||
Cost of goods sold and occupancy expenses | $ | 2,211 | $ | 2,530 | $ | 6,488 | $ | 7,438 | |||||||||||||||
Gross profit | $ | 1,556 | $ | 1,509 | $ | 4,103 | $ | 3,935 | |||||||||||||||
Cost of goods sold and occupancy expenses as a percentage of net sales | 58.7 | % | 62.6 | % | 61.3 | % | 65.4 | % | |||||||||||||||
Gross margin | 41.3 | % | 37.4 | % | 38.7 | % | 34.6 | % |
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
($ in millions) | October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | |||||||||||||||||||
Operating expenses | $ | 1,306 | $ | 1,323 | $ | 3,757 | $ | 3,974 | |||||||||||||||
Operating expenses as a percentage of net sales | 34.7 | % | 32.8 | % | 35.5 | % | 34.9 | % | |||||||||||||||
Operating margin | 6.6 | % | 4.6 | % | 3.3 | % | (0.3) | % |
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
($ in millions) | October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | |||||||||||||||||||
Interest expense | $ | 28 | $ | 22 | $ | 66 | $ | 63 |
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
($ in millions) | October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | |||||||||||||||||||
Interest income | $ | (28) | $ | (4) | $ | (58) | $ | (6) |
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
($ in millions) | October 28, 2023 | October 29, 2022 | October 28, 2023 | October 29, 2022 | |||||||||||||||||||
Income taxes | $ | 32 | $ | (114) | $ | 21 | $ | (167) | |||||||||||||||
Effective tax rate | 12.8 | % | (67.9) | % | 6.2 | % | 174.0 | % |
39 Weeks Ended | |||||||||||
($ in millions) | October 28, 2023 | October 29, 2022 | |||||||||
Net cash provided by (used for) operating activities | $ | 832 | $ | (112) | |||||||
Less: Purchases of property and equipment | (288) | (577) | |||||||||
Free cash flow | $ | 544 | $ | (689) |
Incorporated by Reference | ||||||||||||||||||||||||||||||||||||||
Exhibit No. | Exhibit Description | Form | File No. | Exhibit | Filing Date | Filed/ Furnished Herewith | ||||||||||||||||||||||||||||||||
3.1 | Amended and Restated Certificate of Incorporation (P) | 10-K | 1-7562 | 3.1 | April 26, 1993 | |||||||||||||||||||||||||||||||||
Certificate of Amendment of Amended and Restated Certificate of Incorporation | 10-K | 1-7562 | 3.2 | April 4, 2000 | ||||||||||||||||||||||||||||||||||
Amended and Restated Bylaws (effective August 15, 2022) | 10-Q | 1-7562 | 3.3 | August 26, 2022 | ||||||||||||||||||||||||||||||||||
Amendment, dated August 17, 2023, to Letter Agreement dated August 1, 2022 by and between Bob L. Martin and the Registrant | X | |||||||||||||||||||||||||||||||||||||
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer of The Gap, Inc. (Section 302 of the Sarbanes-Oxley Act of 2002) | X | |||||||||||||||||||||||||||||||||||||
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer of The Gap, Inc. (Section 302 of the Sarbanes-Oxley Act of 2002) | X | |||||||||||||||||||||||||||||||||||||
Certification of the Chief Executive Officer of The Gap, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | |||||||||||||||||||||||||||||||||||||
Certification of the Chief Financial Officer of The Gap, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | |||||||||||||||||||||||||||||||||||||
101 | The following materials from The Gap, Inc.’s Quarterly Report on Form 10-Q for the quarter ended October 28, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Stockholders' Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) Notes to Condensed Consolidated Financial Statements | X | ||||||||||||||||||||||||||||||||||||
104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) | X |
THE GAP, INC. | |||||||||||
Date: | November 21, 2023 | By | /s/ Richard Dickson | ||||||||
Richard Dickson | |||||||||||
President and Chief Executive Officer | |||||||||||
(Principal Executive Officer) | |||||||||||
Date: | November 21, 2023 | By | /s/ Katrina O'Connell | ||||||||
Katrina O'Connell | |||||||||||
Executive Vice President and Chief Financial Officer | |||||||||||
(Principal Financial and Accounting Officer) |
Date: | November 21, 2023 | |||||||
/s/ Richard Dickson | ||||||||
Richard Dickson | ||||||||
President and Chief Executive Officer | ||||||||
(Principal Executive Officer) |
Date: | November 21, 2023 | |||||||
/s/ Katrina O'Connell | ||||||||
Katrina O'Connell | ||||||||
Executive Vice President and Chief Financial Officer | ||||||||
(Principal Financial and Accounting Officer) |
Date: | November 21, 2023 | |||||||
/s/ Richard Dickson | ||||||||
Richard Dickson | ||||||||
President and Chief Executive Officer | ||||||||
(Principal Executive Officer) |
Date: | November 21, 2023 | |||||||
/s/ Katrina O'Connell | ||||||||
Katrina O'Connell | ||||||||
Executive Vice President and Chief Financial Officer | ||||||||
(Principal Financial and Accounting Officer) |